USP30 Inhibitor Program
Parkinson's Disease
Key Facts
About Vincere Biosciences
Vincere Biosciences is a preclinical-stage biotech targeting age-related diseases through the modulation of mitophagy, the cellular process for removing damaged mitochondria. The company has identified USP30 inhibition as its lead mechanism and is advancing a pipeline of small molecules, with the first candidate expected to enter human trials within 12 months. Backed by over $8 million in non-dilutive grant funding and a syndicate of expert investors, Vincere leverages a seasoned, virtual-team model and a strong scientific advisory board to de-risk its drug discovery programs.
View full company profileAbout Vincere Biosciences
Vincere Biosciences is a preclinical-stage biotech targeting age-related diseases through the modulation of mitophagy, the cellular process for removing damaged mitochondria. The company has identified USP30 inhibition as its lead mechanism and is advancing a pipeline of small molecules, with the first candidate expected to enter human trials within 12 months. Backed by over $8 million in non-dilutive grant funding and a syndicate of expert investors, Vincere leverages a seasoned, virtual-team model and a strong scientific advisory board to de-risk its drug discovery programs.
View full company profileTherapeutic Areas
Other Parkinson's Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| NPT200-11 | Neuropore Therapies | Phase 1 |
| NUZ-001 | Neurizon Therapeutics | Preclinical |
| VXX-301 | Vaxxinity | Preclinical |
| BAN2802 | BioArctic | Phase 1 |
| CNM-Au8 | Clene | Phase 2 |
| hpSC-Derived Neural/Dopaminergic Cells | International Stem Cell | Preclinical/Early Clinical |
| SLS-004 | Seelos Therapeutics | Preclinical |
| SLS-007 | Seelos Therapeutics | Preclinical |
| Parkinson's Disease Portfolio (Platform-derived) | WD Pharmaceutical | Not Disclosed (Likely Preclinical/Early Clinical) |
| UX-DA001 | UniXell | Phase 1 |
| Parkinson's Disease Research | ProgenaBiome | Research |
| A9 Dopaminergic Neuron Therapy | Trailhead Biosystems | Pre-clinical |